Pulmonary Alveolar Proteinosis - 18 Studies Found

Recruiting : Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)
: Autoimmune Pulmonary Alveolar Proteinosis
: 2014-09-14
: Drug: GM-CSF Other Name: HUABEI JIMUXIN
Not yet recruiting : Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis
: Autoimmune Pulmonary Alveolar Proteinosis
: 2016-11-28
: Drug: Sargramostim Other Names:
  • Leukine
  • recombinant human GM-C
Recruiting : Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
: Autoimmune Pulmonary Alveolar Proteinosis
: 2016-02-28
:
  • Drug: molgramostim molgramosti
Recruiting : Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (PAP)
: Pulmonary Alveolar Proteinosis
: 2009-05-11
:
  • Drug: GM-CSF [Leukine (Sargramostim)]

Recruiting : A National Registry For Pulmonary Alveolar Proteinosis
: Pulmonary Alveolar Proteinosis
: 2015-05-28
Completed : Multicenter International Cross-Sectional Evaluation of Pulmonary Alveolar Proteinosis Trial
: Pulmonary Alveolar Proteinosis
: 2016-11-28
: Other: Retrospective Chart Review No intervention.
Completed : Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP)
: Hereditary Pulmonary Alveolar Proteinosis
: 2011-12-12
: Drug: Leukine Participants will receive inhaled rhGM-CSF (Sargramostim, Leukine) at the dose of 250 mcg
Terminated : GM-CSF in Patients With Pulmonary Alveolar Proteinosis
: Pulmonary Alveolar Proteinosis
: 2002-01-30
: Drug: GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)
Active, not recruiting : Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan
: Pulmonary Alveolar Proteinosis, Autoimmune
: 2016-07-13
:
  • Drug: Sargramostim
  • Drug: Placebo
Recruiting : Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis
:
  • Pulmonary Alveolar Proteinosis
  • Primary Disease

: 2007-10-31
: Drug: rituximab IV, 1000 mg, two weeks, 2 times Othe
Next >>>